Research and Development Tax Credit Expansion Act of 2025
Research and Development Tax Credit Expansion Act of 2025
Plain Language Summary
# Research and Development Tax Credit Expansion Act of 2025 (HR 4933) **What the Bill Would Do** This bill would expand the research and development (R&D) tax credit, a tax break that currently allows companies to deduct certain expenses related to developing new products, processes, and technologies. While the bill's specific provisions aren't detailed in the available summary, expansion acts of this type typically increase the percentage of qualifying expenses that companies can deduct, broaden which activities count as eligible R&D, or make the credit easier for smaller companies to claim. **Who It Affects and Current Status** The bill primarily affects businesses and corporations that invest in research and development—ranging from pharmaceutical and tech companies to manufacturers and startups. Taxpayers could potentially benefit indirectly through economic growth and job creation if companies increase R&D spending in response to larger tax incentives.
The bill is currently in committee, meaning it has been introduced but hasn't yet moved forward for a full House vote. As of now, it remains in the early stages of the legislative process.
Latest Action
Referred to the House Committee on Ways and Means.